Casdin Partners GP, LLC 4
4 · 2seventy bio, Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
Casdin Capital, LLC
Director
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-03-26$5.10/sh+40,000$203,992→ 2,000,000 total(indirect: See footnote.)
Holdings
- 16,600
Common Stock, par value $0.0001 per share
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $4.9 to $5.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F3]This restricted stock unit award vests ratable over three years in annual installments with the first installment vesting on March 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date.
- [F4]The securities are owned directly by Eli Casdin.